中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2014年
16期
2426-2427
,共2页
银屑病%阿维A%甲氨蝶呤
銀屑病%阿維A%甲氨蝶呤
은설병%아유A%갑안접령
Psoriasis%Acitretin%Methotrexate
目的:探讨阿维A联合甲氨蝶呤治疗难治性泛发性脓疱型银屑病的疗效及安全性。方法169例难治性泛发性脓疱型银屑病患者,采用数字表法随机分为阿维A组、甲氨蝶呤组以及阿维A与甲氨蝶呤联合治疗组,观察不同治疗方法的临床疗效与安全性。结果联合治疗组的总有效率为96.55%,明显高于阿维A组的83.93%以及甲氨蝶呤组的80.00%(χ2=5.210、7.603,均P<0.05)。联合治疗组不良反应发生率为41.38%,显著高于阿维A组的21.43%(χ2=5.251,P<0.05)。结论阿维A联合甲氨蝶呤治疗难治性泛发性脓疱型银屑病的临床疗效显著,安全性好,值得在临床中推广应用。
目的:探討阿維A聯閤甲氨蝶呤治療難治性汎髮性膿皰型銀屑病的療效及安全性。方法169例難治性汎髮性膿皰型銀屑病患者,採用數字錶法隨機分為阿維A組、甲氨蝶呤組以及阿維A與甲氨蝶呤聯閤治療組,觀察不同治療方法的臨床療效與安全性。結果聯閤治療組的總有效率為96.55%,明顯高于阿維A組的83.93%以及甲氨蝶呤組的80.00%(χ2=5.210、7.603,均P<0.05)。聯閤治療組不良反應髮生率為41.38%,顯著高于阿維A組的21.43%(χ2=5.251,P<0.05)。結論阿維A聯閤甲氨蝶呤治療難治性汎髮性膿皰型銀屑病的臨床療效顯著,安全性好,值得在臨床中推廣應用。
목적:탐토아유A연합갑안접령치료난치성범발성농포형은설병적료효급안전성。방법169례난치성범발성농포형은설병환자,채용수자표법수궤분위아유A조、갑안접령조이급아유A여갑안접령연합치료조,관찰불동치료방법적림상료효여안전성。결과연합치료조적총유효솔위96.55%,명현고우아유A조적83.93%이급갑안접령조적80.00%(χ2=5.210、7.603,균P<0.05)。연합치료조불량반응발생솔위41.38%,현저고우아유A조적21.43%(χ2=5.251,P<0.05)。결론아유A연합갑안접령치료난치성범발성농포형은설병적림상료효현저,안전성호,치득재림상중추엄응용。
Objective To discuss the efficacy and security of the treatment of Etretin and Methotrexate on refractory generalized pustular psoriasis .Methods 169 patients with refractory generalized pustular psoriasis were se-lected and randomly divided into 3 groups by the random number table .The efficacy and security were observed . Results The total efficiency of the combination therapy group was 94.83%and it was obviously higher than that of the etretin group and methotrexate group (χ2 =5.210,7.603,all P<0.05).The incidence of adverse reactions of the combination therapy group was 41.38%and it was obviously higher than that of the etretin group (21.43%) (χ2 =5.251,P<0.05) and made no significant difference with the methotrexate group .Conclusion Etretin combined with methotrexate on refractory generalized pustular psoriasis has a significant efficacy and make no difference with methotrexate group on security and deserved promotion .